Original Article
The risk of hepatocellular carcinoma recurrence after liver transplantation increases with locoregional therapies in patients initially within Milan criteria
HepatoBiliary Surgery and Nutrition
2025;
14
(4)
:539-551
.
(01 August 2025)
PDF
Full Text
(462)
Reporting Checklist
Data Sharing Statement
Peer Review File
COI Form
Open Access
The novel study design by including only initially within Milan hepatocellular carcinoma patients enabled clearer view of increasing risk of recurrence with the increasing number of locoregional therapies.
Biliary and respiratory complications after right hepatectomy for hepatocellular carcinoma following selective internal radiation therapy (SIRT): a retrospective case-control study
HepatoBiliary Surgery and Nutrition
2025;
14
(4)
:552-561
.
(01 August 2025)
PDF
Full Text
(369)
Reporting Checklist
Data Sharing Statement
Peer Review File
COI Form
Open Access
SIRT may increase the risk of biliary leakage and diaphragmatic dysfunction after right hepatectomy in cirrhotic patients with hepatocellular carcinoma. Surgeons must be aware of these potential complications while considering the downstaging benefits of this technique.
Hypothermic oxygenated machine perfusion does not increase the risk of infection after liver transplantation: a retrospective cohort study
HepatoBiliary Surgery and Nutrition
2025;
14
(4)
:562-574
.
(01 August 2025)
PDF
Full Text
(295)
Reporting Checklist
Data Sharing Statement
Peer Review File
COI Form
Open Access
This study demonstrates that hypothermic oxygenated machine perfusion in liver transplantation does not increase the risk of infection within 10 days post-transplantation, yielding similar patient and graft outcomes compared to static cold storage and supporting the efficacy of HOPE in expanding the donor pool.
Evaluation of outcomes of robotic liver surgery using the IWATE criteria
HepatoBiliary Surgery and Nutrition
2025;
14
(4)
:575-586
.
(01 August 2025)
PDF
Full Text
(305)
Reporting Checklist
Data Sharing Statement
Peer Review File
COI Form
Open Access
This article emphasizes that the IWATE criteria correlate well with surgical outcomes, and by removing the learning curve, perioperative results can accurately reflect procedural complexity rather than surgeon skills. Implementing this classification system could facilitate a stepwise approach to robotic liver surgery, addressing adoption barriers.
Efficacy of hepatic arterial infusion chemotherapy in advanced hepatocellular carcinoma: survival outcomes and prognostic factors from a systematic review and meta-analysis
HepatoBiliary Surgery and Nutrition
2025;
14
(4)
:587-607
.
(01 August 2025)
Hepatic arterial infusion chemotherapy (HAIC) may offer improved overall and progression-free survival compared to transarterial chemoembolization (TACE) in advanced hepatocellular carcinoma. Evidence suggests HAIC may be particularly beneficial in patients with adverse prognostic factors, while maintaining a more favorable safety profile in selected populations.
Review Article
From critical care to organ preservation: the potential role of hemadsorption in transplantation—a narrative review
HepatoBiliary Surgery and Nutrition
2025;
14
(4)
:608-629
.
(01 August 2025)
Hemadsorption devices, widely studied in sepsis and other conditions with cytokine storm, show promise for organ transplantation, particularly in liver disease. Ex-situ machine perfusion systems provide a valuable platform to investigate its effects on immune response and cellular metabolism, which remain incompletely understood.
French Editorial Commentary from the ACHBPT
Tumor burden score and borderline resectability criteria as predictors of survival in advanced hepatocellular carcinoma
HepatoBiliary Surgery and Nutrition
2025;
14
(4)
:630-633
.
(01 August 2025)
Implications of the surgical approach for complex liver resection in the era of enhanced recovery programs: a critical appraisal of the “Orange Segments” randomized controlled trial
HepatoBiliary Surgery and Nutrition
2025;
14
(4)
:634-638
.
(01 August 2025)
Editorial Commentary
Quest for an accurate and reproducible prognostic biomarker of severe acute pancreatitis: have we finally found it?
HepatoBiliary Surgery and Nutrition
2025;
14
(4)
:639-642
.
(01 August 2025)
Updates on the impact of the new liver allocation policy on national liver transplants
HepatoBiliary Surgery and Nutrition
2025;
14
(4)
:643-646
.
(01 August 2025)
De-escalating local therapies without compromising outcomes: lessons from the COLLISION trial
HepatoBiliary Surgery and Nutrition
2025;
14
(4)
:647-650
.
(01 August 2025)
Empagliflozin for non-diabetic metabolic dysfunction-associated steatotic liver disease: a promising therapeutic agent in transition
HepatoBiliary Surgery and Nutrition
2025;
14
(4)
:651-654
.
(01 August 2025)
Neuroendocrine liver metastasis
HepatoBiliary Surgery and Nutrition
2025;
14
(4)
:655-657
.
(01 August 2025)
Listening to the spleen: a 100 Hz pulse toward a non-invasive way in assessing portal hypertension
HepatoBiliary Surgery and Nutrition
2025;
14
(4)
:658-661
.
(01 August 2025)
Advancing surgical techniques: a first application of remote robotic pancreaticoduodenectomy for resectable malignant tumor
HepatoBiliary Surgery and Nutrition
2025;
14
(4)
:662-664
.
(01 August 2025)
Navigating abdominal surgery in extrahepatic portal vein obstruction: new insights and remaining issues
HepatoBiliary Surgery and Nutrition
2025;
14
(4)
:665-668
.
(01 August 2025)
Can portable artificial livers become an alternative to liver transplantation in the future?
HepatoBiliary Surgery and Nutrition
2025;
14
(4)
:669-672
.
(01 August 2025)
Balancing efficacy and tolerability in metastatic pancreatic cancer: lessons from the ALPACA trial
HepatoBiliary Surgery and Nutrition
2025;
14
(4)
:673-675
.
(01 August 2025)
Beyond chemotherapy in biliary tract cancer: a closer look at the updated long-term follow-up data of the TOPAZ-1 trial
HepatoBiliary Surgery and Nutrition
2025;
14
(4)
:676-679
.
(01 August 2025)
How to improve the care of decompensated cirrhosis: the intervention model for chronic disease management
HepatoBiliary Surgery and Nutrition
2025;
14
(4)
:680-682
.
(01 August 2025)
Auxiliary liver transplantation using otherwise-discarded liver allograft combined with associating liver partition and portal vein ligation for staged hepatectomy for unresectable colorectal liver metastases
HepatoBiliary Surgery and Nutrition
2025;
14
(4)
:683-688
.
(01 August 2025)
The value of tranexamic acid in liver resection should not be exaggerated or ignored
HepatoBiliary Surgery and Nutrition
2025;
14
(4)
:689-691
.
(01 August 2025)
Construction and application of multicellular tumor microenvironment models based on three-dimensional bioprinting technology
HepatoBiliary Surgery and Nutrition
2025;
14
(4)
:692-696
.
(01 August 2025)
Editorial
Running towards liver transplantation
HepatoBiliary Surgery and Nutrition
2025;
14
(4)
:697-699
.
(01 August 2025)
Navigating the complexity of colorectal liver metastasis: molecular profiling and tumor sidedness
HepatoBiliary Surgery and Nutrition
2025;
14
(4)
:700-702
.
(01 August 2025)
New perspectives in biology-driven treatment of cholangiocarcinoma: from oncological resectability to genetic breakthroughs and AI-powered imaging
HepatoBiliary Surgery and Nutrition
2025;
14
(4)
:703-708
.
(01 August 2025)
Developing a new source for organ transplantation
HepatoBiliary Surgery and Nutrition
2025;
14
(4)
:709-711
.
(01 August 2025)
Call a spade a spade
HepatoBiliary Surgery and Nutrition
2025;
14
(4)
:712-715
.
(01 August 2025)
Letter to the Editor
Primary Epstein-Barr virus-positive inflammatory follicular dendritic cell sarcoma concurrent with lymphoepithelioma-like intrahepatic cholangiocarcinoma and cavernous hemangioma in liver
HepatoBiliary Surgery and Nutrition
2025;
14
(4)
:716-719
.
(01 August 2025)
An intriguing case of macrolides-induced pancreatic injury mimicking pancreatic carcinoma
HepatoBiliary Surgery and Nutrition
2025;
14
(4)
:720-723
.
(01 August 2025)
